A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients. 2009

John F M Gleeson, and Sue M Cotton, and Mario Alvarez-Jimenez, and Darryl Wade, and Donna Gee, and Kingsley Crisp, and Tracey Pearce, and Belinda Newman, and Daniela Spiliotacopoulos, and David Castle, and Patrick D McGorry
Department of Psychology, ORYGEN Youth Health Research Centre, Melbourne, Victoria, 3010, Australia. jgleeson@unimelb.edu.au

OBJECTIVE Patients with first-episode psychosis are responsive to acute-phase treatments, but relapse rates are high. This study aimed to evaluate the effectiveness of a psychosocial treatment designed to prevent the second episode of psychosis compared with standardized early psychosis care. METHODS In a randomized controlled trial, conducted at the Early Psychosis Prevention and Intervention Centre and Barwon Health, Australia, a multimodal individual and family cognitive-behavioral therapy for relapse prevention was compared with standardized case management within a specialist early psychosis service. Patients aged 15 to 25 years with a first episode of a DSM-IV psychotic disorder were recruited between November 2003 and May 2005. The main outcome measures were the number of relapses and time to first relapse. RESULTS Forty-one first-episode psychosis patients were randomly assigned to the relapse prevention therapy (RPT) and 40 to standardized case management. At the 7-month follow up, the relapse rate was significantly lower in the therapy condition compared to treatment as usual (p = .042) and time to relapse was significantly longer for the RPT condition (p = .03). The number needed to treat was 6 over 7 months. CONCLUSIONS Interim findings suggest that RPT provided within a specialist early psychosis program was effective in reducing relapse in early psychosis when compared with standardized early psychosis case management. BACKGROUND www.anzctr.org.au Identifier: ACTRN12605000514606.

UI MeSH Term Description Entries
D008297 Male Males
D010054 Brief Psychiatric Rating Scale A scale comprising 18 symptom constructs chosen to represent relatively independent dimensions of manifest psychopathology. The initial intended use was to provide more efficient assessment of treatment response in clinical psychopharmacology research; however, the scale was readily adapted to other uses. (From Hersen, M. and Bellack, A.S., Dictionary of Behavioral Assessment Techniques, p. 87) Overall and Gorham Brief Psychiatric Rating Scale,Overall-Gorham Brief Psychiatric Rating Scale,Overall Gorham Brief Psychiatric Rating Scale
D011618 Psychotic Disorders Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994) Psychoses,Psychosis, Brief Reactive,Schizoaffective Disorder,Schizophreniform Disorders,Psychosis,Brief Reactive Psychoses,Brief Reactive Psychosis,Disorder, Psychotic,Disorder, Schizoaffective,Disorder, Schizophreniform,Disorders, Psychotic,Disorders, Schizoaffective,Disorders, Schizophreniform,Psychoses, Brief Reactive,Psychotic Disorder,Reactive Psychoses, Brief,Reactive Psychosis, Brief,Schizoaffective Disorders,Schizophreniform Disorder
D011788 Quality of Life A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral, social environment as well as health and disease. HRQOL,Health-Related Quality Of Life,Life Quality,Health Related Quality Of Life
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012720 Severity of Illness Index Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder. Illness Index Severities,Illness Index Severity
D014150 Antipsychotic Agents Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. Antipsychotic,Antipsychotic Agent,Antipsychotic Drug,Antipsychotic Medication,Major Tranquilizer,Neuroleptic,Neuroleptic Agent,Neuroleptic Drug,Neuroleptics,Tranquilizing Agents, Major,Antipsychotic Drugs,Antipsychotic Effect,Antipsychotic Effects,Antipsychotics,Major Tranquilizers,Neuroleptic Agents,Neuroleptic Drugs,Tranquillizing Agents, Major,Agent, Antipsychotic,Agent, Neuroleptic,Drug, Antipsychotic,Drug, Neuroleptic,Effect, Antipsychotic,Major Tranquilizing Agents,Major Tranquillizing Agents,Medication, Antipsychotic,Tranquilizer, Major

Related Publications

John F M Gleeson, and Sue M Cotton, and Mario Alvarez-Jimenez, and Darryl Wade, and Donna Gee, and Kingsley Crisp, and Tracey Pearce, and Belinda Newman, and Daniela Spiliotacopoulos, and David Castle, and Patrick D McGorry
December 2005, Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists,
John F M Gleeson, and Sue M Cotton, and Mario Alvarez-Jimenez, and Darryl Wade, and Donna Gee, and Kingsley Crisp, and Tracey Pearce, and Belinda Newman, and Daniela Spiliotacopoulos, and David Castle, and Patrick D McGorry
October 2019, Journal of clinical psychology,
John F M Gleeson, and Sue M Cotton, and Mario Alvarez-Jimenez, and Darryl Wade, and Donna Gee, and Kingsley Crisp, and Tracey Pearce, and Belinda Newman, and Daniela Spiliotacopoulos, and David Castle, and Patrick D McGorry
June 2023, Psychological medicine,
John F M Gleeson, and Sue M Cotton, and Mario Alvarez-Jimenez, and Darryl Wade, and Donna Gee, and Kingsley Crisp, and Tracey Pearce, and Belinda Newman, and Daniela Spiliotacopoulos, and David Castle, and Patrick D McGorry
June 2022, International journal of environmental research and public health,
John F M Gleeson, and Sue M Cotton, and Mario Alvarez-Jimenez, and Darryl Wade, and Donna Gee, and Kingsley Crisp, and Tracey Pearce, and Belinda Newman, and Daniela Spiliotacopoulos, and David Castle, and Patrick D McGorry
August 2003, The Australian and New Zealand journal of psychiatry,
John F M Gleeson, and Sue M Cotton, and Mario Alvarez-Jimenez, and Darryl Wade, and Donna Gee, and Kingsley Crisp, and Tracey Pearce, and Belinda Newman, and Daniela Spiliotacopoulos, and David Castle, and Patrick D McGorry
July 2016, Trials,
John F M Gleeson, and Sue M Cotton, and Mario Alvarez-Jimenez, and Darryl Wade, and Donna Gee, and Kingsley Crisp, and Tracey Pearce, and Belinda Newman, and Daniela Spiliotacopoulos, and David Castle, and Patrick D McGorry
December 2007, The Journal of clinical psychiatry,
John F M Gleeson, and Sue M Cotton, and Mario Alvarez-Jimenez, and Darryl Wade, and Donna Gee, and Kingsley Crisp, and Tracey Pearce, and Belinda Newman, and Daniela Spiliotacopoulos, and David Castle, and Patrick D McGorry
April 2004, Psychological medicine,
John F M Gleeson, and Sue M Cotton, and Mario Alvarez-Jimenez, and Darryl Wade, and Donna Gee, and Kingsley Crisp, and Tracey Pearce, and Belinda Newman, and Daniela Spiliotacopoulos, and David Castle, and Patrick D McGorry
January 2011, BMC psychiatry,
John F M Gleeson, and Sue M Cotton, and Mario Alvarez-Jimenez, and Darryl Wade, and Donna Gee, and Kingsley Crisp, and Tracey Pearce, and Belinda Newman, and Daniela Spiliotacopoulos, and David Castle, and Patrick D McGorry
August 2006, Acta psychiatrica Scandinavica,
Copied contents to your clipboard!